Missed opportunities in physician management of glucocorticoid‐induced osteoporosis?
Open Access
- 12 December 2002
- journal article
- editorial
- Published by Wiley in Arthritis & Rheumatism
- Vol. 46 (12) , 3115-3120
- https://doi.org/10.1002/art.10619
Abstract
No abstract availableThis publication has 48 references indexed in Scilit:
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Bone Quality: Getting Closer to a DefinitionJournal of Bone and Mineral Research, 2002
- Barriers to Osteoporosis Identification and Treatment Among Primary Care Physicians and Orthopedic SurgeonsMayo Clinic Proceedings, 2002
- Bone Turnover Matters: The Raloxifene Treatment Paradox of Dramatic Decreases in Vertebral Fractures Without Commensurate Increases in Bone DensityJournal of Bone and Mineral Research, 2002
- Use of Inhaled Corticosteroids and Risk of FracturesJournal of Bone and Mineral Research, 2001
- Corticosteroids and Fractures: A Close Encounter of the Third Cell KindJournal of Bone and Mineral Research, 2000
- Prevention of corticosteroid-induced osteoporosis: Results of a patient surveyArthritis & Rheumatism, 1999
- Medical Expenditures for the Treatment of Osteoporotic Fractures in the United States in 1995: Report from the National Osteoporosis FoundationJournal of Bone and Mineral Research, 1997
- Steroid induced osteoporosis: an opportunity for prevention?Annals of the Rheumatic Diseases, 1995
- Steroid-Induced Fractures and Bone Loss in Patients with AsthmaNew England Journal of Medicine, 1983